PNC Financial Services Group
ALBO

PNC Financial Services Group’s Albireo Pharma Inc ALBO Stock Holding History

PNC Financial Services Group’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,000
Closed -$19K – 4890
2022
Q3 		$19K Buy
+1,000
New +$20.7K ﹤0.01% 3481
2013
Q4 		– Sell
-33
Closed -$3K – 3612
2013
Q3 		$3K Hold
33
– – ﹤0.01% 3468
2013
Q2 		$4K Buy
+33
New +$3.43K ﹤0.01% 3333

Other funds holding ALBO

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return

PNC Financial Services Group's ALBO Position: Q4 2022 in Review

PNC Financial Services Group sold out of Albireo Pharma Inc (ALBO) in Q4 2022, closing a stake of 1,000 shares — an estimated $19K sold.

PNC Financial Services Group first reported a position in ALBO in Q2 2013 and held it in 3 quarters. The position peaked at $19K in Q3 2022. 96 funds tracked by Wall St. Rank hold ALBO as of Q4 2022.

  • PNC Financial Services Group reported no remaining Albireo Pharma Inc position as of Q4 2022 after selling out during the quarter.
  • PNC Financial Services Group sold 1,000 Albireo Pharma Inc shares in Q4 2022, an estimated $19K.
  • PNC Financial Services Group first reported a position in Albireo Pharma Inc in Q2 2013 and held it in 3 quarters.
  • PNC Financial Services Group's Albireo Pharma Inc position peaked at $19K in Q3 2022.
  • 96 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q4 2022.

Based on PNC Financial Services Group's 13F filing for Q4 2022, filed 10 Feb 2023.